Cydan II
Cambridge, US · Founded 2017 · Delaware corporation · 4 known investors
Find your way into Cydan II
Founders & leadership
CM
Christoph M. AdamsNamed on SEC filing
JM
James McArthurNamed on SEC filing
Board
DM
MK
Mette Kirstine AggerBoard director
BD
Barbara DaltonBoard director
SA
Sandip AgarwalaBoard director
SN
Sara NayeemBoard director
Investors · 4
Reported raises · per SEC filings
Form D private placements$10.7M disclosed across 1 round · 2017
▶$10.7MraisedOct 2017 · 5 investors · BiotechnologyRule 506(b)
▶$10.7MraisedOct 2017 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Christoph M. AdamsExecutive Officer, Director
- James McArthurExecutive Officer
- David MottDirector
- Mette Kirstine AggerDirector
- Barbara DaltonDirector
- Sandip AgarwalaDirector
- Sara NayeemDirector
- Offering amount
- $34M
- Amount sold
- $10.7M
- First sale
- Sep 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Cydan II's investors?
- Cydan II's investors include Alexandria, Longitude Capital, New Enterprise Associates (NEA), Pfizer Venture Investments.
- How much funding has Cydan II raised?
- Cydan II has disclosed $10.7M raised across 1 round.
- Where is Cydan II headquartered?
- Cydan II is headquartered in Cambridge, US.